Elevance Health, Inc. (ELV) operating KPIs
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3012% below fair value
$420.07−1.95 (-0.46%)
Close on Oct 30, 2026Market cap $91.10BP/E 18.7Yield –
Elevance Health carelonRx — Affiliated (Intersegment) Operating Revenue ($M)
Quarterly figures from Elevance Health's filings and investor materials
Latest, Q3 2026
5,144
Period ended Sep 30, 2026
Change on a year earlier
+6.4%
4,834 in Q3 2025
History
19 quarters
Since Q1 2022
Sources
16
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | CarelonRx — Affiliated (Intersegment) Operating Revenue ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 5,144 | +6.4% | 10-Q (2026-10-21) ↗ |
| Q2 2026 | Jun 30, 2026 | 4,983 | +8.4% | 10-Q (2026-07-15) ↗ |
| Q1 2026 | Mar 31, 2026 | 4,371 | +1.6% | 10-Q (2026-04-22) ↗ |
| Q4 2025 | Dec 31, 2025 | 5,182 | +58.9% | Tách kỳ Q4 = FY2025 (10-K (FY2025, 2026-02-06)) − 9M2025 (10-Q (2026-10-21)) ↗ |
| Q3 2025 | Sep 30, 2025 | 4,834 | +48.6% | 10-Q (2026-10-21) ↗ |
| Q2 2025 | Jun 30, 2025 | 4,597 | +41.8% | 10-Q (2026-07-15) ↗ |
| Q1 2025 | Mar 31, 2025 | 4,304 | +20.7% | 10-Q (2026-04-22) ↗ |
| Q4 2024 | Dec 31, 2024 | 3,262 | -4.9% | Tách kỳ Q4 = FY2024 (10-K (FY2025, 2026-02-06)) − 9M2024 (10-Q (2025-10-21)) ↗ |
| Q3 2024 | Sep 30, 2024 | 3,254 | -2.5% | 10-Q (2025-10-21) ↗ |
| Q2 2024 | Jun 30, 2024 | 3,243 | -10.1% | 10-Q (2025-07-17) ↗ |
| Q1 2024 | Mar 31, 2024 | 3,567 | -10.9% | 10-Q (2025-04-22) ↗ |
| Q4 2023 | Dec 31, 2023 | 3,431 | +1.3% | Tách kỳ Q4 = FY2023 (10-K (FY2025, 2026-02-06)) − 9M2023 (10-Q (2024-10-17)) ↗ |
| Q3 2023 | Sep 30, 2023 | 3,337 | +1.8% | 10-Q (2024-10-17) ↗ |
| Q2 2023 | Jun 30, 2023 | 3,607 | +3.0% | 10-Q (2024-07-17) ↗ |
| Q1 2023 | Mar 31, 2023 | 4,002 | +18.3% | 10-Q (2024-04-18) ↗ |
| Q4 2022 | Dec 31, 2022 | 3,386 | – | Tách kỳ Q4 = FY2022 (10-K (FY2024, 2025-02-20)) − 9M2022 (10-Q (2023-10-18)) ↗ |
| Q3 2022 | Sep 30, 2022 | 3,277 | – | 10-Q (2023-10-18) ↗ |
| Q2 2022 | Jun 30, 2022 | 3,503 | – | 10-Q (2023-07-19) ↗ |
| Q1 2022 | Mar 31, 2022 | 3,382 | – | 10-Q (2023-04-19) ↗ |
Cite this data
StockData. (2026). Elevance Health CarelonRx — Affiliated (Intersegment) Operating Revenue ($M), quarterly Q1 2022–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/seg_carelonrx_rev_affiliated
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.